CEACAM5 and neoplasm: In a context where specific nuclear DNA targeting is still challenging, our group previously showed that AEE-based TRT with 125I-labelled non-internalising monoclonal antibodies (mAbs) against carcinoembryonic antigen (CEA) leads to significant tumour growth delay in preclinical mouse models harbouring small tumours [18].